問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberD910VC00001
NCT Number(ClinicalTrials.gov Identfier)-
Active

2022-03-31 - 2027-12-31

Phase III

Not yet recruiting4

Recruiting1

ICD-10C22.0

Liver cell carcinoma

ICD-10C22.2

Hepatoblastoma

ICD-10C22.3

Angiosarcoma of liver

ICD-10C22.4

Other sarcomas of liver

ICD-10C22.7

Other specified carcinomas of liver

ICD-10C22.8

Malignant neoplasm of liver, primary, unspecified as to type

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9155.0

Malignant neoplasm of liver, primary

-

  • Trial Applicant

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/14

Investigators and Locations

Principal Investigator Yee Chao Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator TENG-YU LEE Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chen-Chun Lin Digestive System Department

Co-Principal Investigator

Principal Investigator Chang-Fang Chiu Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chih-Hung Hsu

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    60 participants

  • Global

    725 participants